🔎 Trials Near Me

Dachaigh › Obesity › Utah

Sgrùdaidhean clionaigeach Obesity ann an Utah

Tha 29 sgrùdaidhean airson Obesity a’ lorg phàirtichean aig làraichean ann an Utah.

Bailtean ann an Utah

Teacsa sgrùdaidh oifigeil (Beurla)

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

  • Pantheon Clinical Research, Bountiful
  • Alliance for Multispecialty Research Layton Research Center, Layton
  • Chrysalis Clinical Research, LLC, St. George
A’ fastadhÌre 3
Aoisean 18 gu 99 · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT07684235

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

  • Boeson Research, Provo
  • Velocity Clinical Research - Salt Lake City, West Jordan
A’ fastadhÌre 3
Aoisean 45 gu 99 · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT07037433

Partnership to Reduce Obesity in Community Health Center Patients (SMARTLife Utah)

  • Huntsman Cancer Institute at the University of Utah, Salt Lake City
A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT07582016

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

  • AMR Clinical, Layton
A’ fastadhÌre 3
Aoisean 8 gu 18 · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT07253285

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

  • Ogden Clinic - Canyon View, Ogden
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT07783802

Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss

  • AMR Clinical, South Jordan
A’ fastadhÌre 2
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT07837973

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

  • Velocity Clinical Research, Salt Lake City, West Jordan
A’ fastadhÌre 3
Aoisean 6 gu 17 · Gach gnè · Air ùrachadh 24 Sult 2026 · NCT06672549

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

  • Ogden Clinic - Canyon View, Ogden
  • Diabetes & Endocrine Treatment Specialists, Sandy City
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07282600

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

  • AMR Clinical, South Jordan
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT07353931

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

  • AURORA-2 Clinical Site, Salt Lake City
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 16 Sult 2026 · NCT07743450

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

  • AURORA-1 Clinical Site, Salt Lake City
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 16 Sult 2026 · NCT07743463

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

  • George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 14 Sult 2026 · NCT07351045

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

  • ACCOMPLISH-2 Research Site, Salt Lake City
A’ fastadhÌre 3Fàilte do shaor-thoilich fhallain
Aoisean 18 gu 79 · Gach gnè · Air ùrachadh 11 Sult 2026 · NCT07654374

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

  • Kalo Clinical Research, West Valley City
A’ fastadhÌre 2
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 8 Sult 2026 · NCT07215559

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

  • Kailera Clinical Site, Pleasant View
  • Kailera Clinical Site, Salt Lake City
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 3 Sult 2026 · NCT07284901

Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes

  • Kailera Clinical Site, Salt Lake City
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 3 Sult 2026 · NCT07284875

A Study of LY4174794 in Participants With Obesity or Overweight Who Are Otherwise Healthy

  • ICON Early Phase Services, LLC, Salt Lake City
A’ fastadhÌre 1Fàilte do shaor-thoilich fhallain
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 1 Sult 2026 · NCT07654972

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

  • Research Site, Salt Lake City
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT07784725

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

  • Primary Children's Hospital, Salt Lake City
A’ fastadhÌre 2
Aoisean 7 gu 25 · Gach gnè · Air ùrachadh 19 Lùna 2026 · NCT05082519

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

  • Intermountain Medical Center, Murray
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 18 Lùna 2026 · NCT07567001

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

  • ACCOMPLISH-1 Research Site, Sandy City
  • ACCOMPLISH-1 Research Site, St. George
A’ fastadhÌre 3
Aoisean 18 gu 79 · Gach gnè · Air ùrachadh 10 Lùna 2026 · NCT07654361

Circadian Intervention to Improve Cardiometabolic Health

  • College of Health Research Complex--University of Utah, Salt Lake City
A’ fastadhFàilte do shaor-thoilich fhallain
Aoisean 18 gu 45 · Gach gnè · Air ùrachadh 5 Lùna 2026 · NCT05943626

Effect of Sleep Extension on Ceramides in People With Overweight and Obesity

  • College of Health Research Complex--University of Utah, Salt Lake City
A’ fastadhFàilte do shaor-thoilich fhallain
Aoisean 18 gu 45 · Gach gnè · Air ùrachadh 5 Lùna 2026 · NCT06180837

Sit Less, Interact and Move More (SLIMM) 2 Study

  • University of Utah, Salt Lake City
A’ fastadhÌre 2
Aoisean 20 agus nas sine · Gach gnè · Air ùrachadh 27 Iuch 2026 · NCT05173714

Testing a Tailored Approach to Long-Term Weight Loss Success

  • University of Utah, Salt Lake City
A’ fastadhFàilte do shaor-thoilich fhallain
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 11 Cèit 2026 · NCT07577765

A Study of RM-718 in Healthy Subjects and Patients With MC4R Pathway Impairment

  • University of Utah Pediatric Endocrine Clinic (Part C and Part D), Salt Lake City
A’ fastadhÌre 1/2Fàilte do shaor-thoilich fhallain
Aoisean 12 gu 65 · Gach gnè · Air ùrachadh 22 Dùbh 2025 · NCT06239116

PreventT2 Together: Examining the Efficacy of Couple-based Lifestyle Intervention to Prevent Type 2 Diabetes

  • University of Utah, Salt Lake City
A’ fastadhFàilte do shaor-thoilich fhallain
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 30 Cèit 2025 · NCT06690788

The Acute T-Rex (Timing of Resistance Exercise) Study

  • University of Utah HPER E Buildling, Salt Lake City
A’ fastadh
Aoisean 50 gu 74 · Gach gnè · Air ùrachadh 3 Gibl 2025 · NCT06366399

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.